110 related articles for article (PubMed ID: 3358635)
1. Effects of the 6-alkyl substitution of ellipticine on the uptake by NIH-3T3 cells and on the cytotoxicity.
Deprés JP; Larue L; Paoletti J; Gouyette A
Anticancer Res; 1988; 8(1):191-6. PubMed ID: 3358635
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of ellipticine and aza-analogue derivatives on cell cycle progression and survival of BALB/c 3T3 cells released from serum starvation or thymidine double block.
Vilarem MJ; Charcosset JY; Primaux F; Gras MP; Calvo F; Larsen CJ
Cancer Res; 1985 Aug; 45(8):3906-11. PubMed ID: 4016757
[TBL] [Abstract][Full Text] [Related]
3. Uptake, cytofluorescence, and cytotoxicity of oxazolopyridocarbazoles (amino acid-ellipticine conjugates) in murine sarcoma cells.
Larsen AK; Paoletti J; Belehradek J; Paoletti C
Cancer Res; 1986 Oct; 46(10):5236-40. PubMed ID: 3756875
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of the anti-tumour drugs N2-methyl-9-hydroxyellipticinium acetate (NSC 264137) and N2-methyl-9-hydroxyolivacinium acetate in the rat: preliminary identification of biliary 9-(O)-glucuronide and 10-(S)-glutathione conjugates.
Maftouh M; Meunier G; Dugue B; Monsarrat B; Meunier B; Paoletti C
Xenobiotica; 1983 May; 13(5):303-10. PubMed ID: 6636827
[TBL] [Abstract][Full Text] [Related]
5. Covalent binding of elliptinium acetate (NSC 264137) to nucleic acids of L1210 cells in culture.
Dugue B; Auclair C; Meunier B
Cancer Res; 1986 Aug; 46(8):3828-33. PubMed ID: 2425935
[TBL] [Abstract][Full Text] [Related]
6. Uptake and cytofluorescence localization of ellipticine derivatives in sensitive and resistant Chinese hamster lung cells.
Charcosset JY; Salles B; Jacquemin-Sablon A
Biochem Pharmacol; 1983 Mar; 32(6):1037-44. PubMed ID: 6838650
[TBL] [Abstract][Full Text] [Related]
7. The biooxidation of cytotoxic ellipticine derivatives: a key to structure-activity relationship studies?
Meunier G; De Montauzon D; Bernadou J; Grassy G; Bonnafous M; Cros S; Meunier B
Mol Pharmacol; 1988 Jan; 33(1):93-102. PubMed ID: 3336351
[TBL] [Abstract][Full Text] [Related]
8. [Sanguinarine and ellipticine cytotoxic alkaloids isolated from well-known antitumor plants. Intracellular targets of their action].
Faddeeva MD; Beliaeva TN
Tsitologiia; 1997; 39(2-3):181-208. PubMed ID: 9312909
[TBL] [Abstract][Full Text] [Related]
9. A new series of ellipticine derivatives (1-(alkylamino)-9-methoxyellipticine). Synthesis, DNA binding, and biological properties.
Larue L; Rivalle C; Muzard G; Paoletti C; Bisagni E; Paoletti J
J Med Chem; 1988 Oct; 31(10):1951-6. PubMed ID: 3172128
[TBL] [Abstract][Full Text] [Related]
10. Evidence for electrophilic properties of N2-methyl-9-hydroxy ellipticinium acetate (Celiptium) from human biliary metabolites.
Bernadou J; Monsarrat B; Roche H; Armand JP; Paoletti C; Meunier B
Cancer Chemother Pharmacol; 1985; 15(1):63-5. PubMed ID: 4006051
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and biological evaluation of ellipticine-estradiol conjugates.
Devraj R; Barrett JF; Fernandez JA; Katzenellenbogen JA; Cushman M
J Med Chem; 1996 Aug; 39(17):3367-74. PubMed ID: 8765520
[TBL] [Abstract][Full Text] [Related]
12. Biological properties of 5,11-dimethyl-6H-pyrido[3,2-b]carbazoles: a new class of potent antitumour drugs.
Moinet-Hedin V; Tabka T; Poulain L; Godard T; Lechevrel M; Saturnino C; Lancelot JC; Le Talaër JY; Gauduchon P
Anticancer Drug Des; 2000 Apr; 15(2):109-18. PubMed ID: 10901298
[TBL] [Abstract][Full Text] [Related]
13. Cellular uptake as a determinant of cytotoxicity of quaternized ellipticines to human brain tumor cells.
Vistica DT; Kenney S; Hursey ML; Boyd MR
Biochem Biophys Res Commun; 1994 May; 200(3):1762-8. PubMed ID: 8185636
[TBL] [Abstract][Full Text] [Related]
14. Influence of inducers of monooxygenases on cytotoxic efficiency of ellipticine on leukemia L1210 cells.
Lesca P; Monsarrat B; Cros S; Paoletti C
J Natl Cancer Inst; 1981 Oct; 67(4):871-6. PubMed ID: 6944554
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic effects of the lysosomotropic agents DNA-ellipticine, DNA-daunorubicin, and DNA-ellipticine:daunorubicin on L1210 leukemia cells.
Sorace RA; Sheid B
Cancer Treat Rep; 1979 Jan; 63(1):43-51. PubMed ID: 421232
[No Abstract] [Full Text] [Related]
16. The mechanism of cytotoxicity and DNA adduct formation by the anticancer drug ellipticine in human neuroblastoma cells.
Poljaková J; Eckschlager T; Hrabeta J; Hrebacková J; Smutný S; Frei E; Martínek V; Kizek R; Stiborová M
Biochem Pharmacol; 2009 May; 77(9):1466-79. PubMed ID: 19426684
[TBL] [Abstract][Full Text] [Related]
17. [Metabolism and pharmacokinetics of methoxy-9-ellipticine and its principal metabolite, hydroxy-9-ellipticine].
Lecointe P; Puget A
C R Seances Acad Sci III; 1983; 296(6):279-82. PubMed ID: 6405990
[TBL] [Abstract][Full Text] [Related]
18. Interaction between ellipticine derivatives and circular supercoiled DNA as revealed by gel electrophoresis. Possible relationship with the mechanisms of cytotoxicity .
Malvy C; Cros S
Biochem Pharmacol; 1986 Jul; 35(13):2264-7. PubMed ID: 3729982
[No Abstract] [Full Text] [Related]
19. [Demonstration of an oxidative biotransformation of 9-methoxyellipticine. Comparison with the case of 9-hydroxyellipticine].
Braham Y; Meunier G; Meunier B
C R Acad Sci III; 1987; 304(11):301-6. PubMed ID: 3103875
[TBL] [Abstract][Full Text] [Related]
20. Binding to DNA, cellular uptake and biological activity of a distamycin-ellipticine hybrid molecule.
Bailly C; Leclere V; Pommery N; Colson P; Houssier C; Rivalle C; Bisagni E; Hénichart JP
Anticancer Drug Des; 1993 Apr; 8(2):145-64. PubMed ID: 8494604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
